二甲基甲酰胺市场－全球产业规模、份额、趋势、机会和预测，按类型（反应物、原料）、按最终用户（化学、电子、製药、农业）、按地区和竞争细分，2020-2030 年

2024 年全球二甲基甲酰胺市场价值为 25.3 亿美元，预计到 2030 年将达到 29.7 亿美元，复合年增长率为 2.84%。二甲基甲酰胺 (DMF) 是一种广泛使用的无色有机溶剂，以其在工业和化学应用中的多功能性而闻名。 DMF 的化学表示为 (CH3)2NC(O)H，是一种亲水性非质子溶剂，沸点高，使其成为促进 SN2 机制等极性反应的理想选择。它与水和各种有机化合物结合时会形成均相混合物，因此广泛应用于化学合成。 DMF 主要由甲酸和二甲胺反应生成。然而，它在强酸或强碱中化学不稳定，会水解成甲酸和二甲胺。由于其高水溶性、有机性质和缓慢的蒸发速度，DMF 仍然是多个工业领域的首选溶剂。

儘管DMF在工业上具有重要意义，但它也带来了严重的健康和安全隐患，影响着市场动态。研究表明，接触DMF可能导致潜在的致癌作用和疑似先天性残疾，这导致某些地区推出了监管限制，尤其限制了女性在接触DMF的工作场所的接触。虽然国际癌症研究机构（IARC）将DMF归类为潜在致癌物，但美国环保署（EPA）并不认为有明确的致癌风险。然而，根据EPA报告，急性暴露于DMF可能导致严重的健康问题，包括肝衰竭，这对其市场接受度和成长构成了严峻挑战。因此，许多行业正在转向更安全的替代品，例如二甲基亚砜（DMSO），以降低健康风险。

关键市场驱动因素

製药业对二甲基甲酰胺的需求不断增长

主要市场挑战

原料成本波动

主要市场趋势

高纯度DMF的需求不断成长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：全球二甲基甲酰胺市场展望

• 市场规模和预测
  • 按价值和数量
• 市场占有率和预测
  • 依类型（反应物、原料）
  • 依最终用户（化工、电子、製药、农业）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按类型
  • 按最终用户
  • 按地区

第五章：亚太二甲基甲酰胺市场展望

• 市场规模和预测
  • 按价值和数量
• 市场占有率和预测
  • 按类型
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第六章：欧洲二甲基甲酰胺市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第七章：北美二甲基甲酰胺市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第八章：南美洲二甲基甲酰胺市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第九章：中东和非洲二甲基甲酰胺市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 埃及

第十章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 12 章：全球二甲基甲酰胺市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• BASF SE
• Balaji Amines Ltd.
• Bell Chem Corp
• Methanol Chemicals Co.
• Eastman Chemical Company
• Jiutian Chemical Group Ltd.
• Luxi Group Co Ltd
• Mitsubishi Gas Chemical Company Inc.
• PON Pure Chemical India Pvt Ltd
• Shandong Hualu-Hengsheng Chemical Co., Ltd.

第 15 章：策略建议

第16章调查会社について・免责事项

Global Dimethylformamide Market was valued at USD 2.53 Billion in 2024 and is expected to reach USD 2.97 Billion by 2030 with a CAGR of 2.84%. Dimethylformamide (DMF) is a widely used, colorless organic solvent known for its versatility in industrial and chemical applications. Chemically represented as (CH3)2NC(O)H, DMF serves as a hydrophilic aprotic solvent with a high boiling point, making it ideal for facilitating polar reactions such as SN2 mechanisms. It forms homogeneous mixtures when combined with water and various organic compounds, contributing to its widespread use in chemical synthesis. DMF is primarily produced through the reaction of formic acid and dimethylamine. However, it is chemically unstable when exposed to strong acids or bases, undergoing hydrolysis into formic acid and dimethylamine. Due to its high water solubility, organic nature, and slow evaporation rate, DMF remains a preferred solvent across multiple industrial sectors.

Despite its industrial importance, DMF poses significant health and safety concerns that affect market dynamics. Research has linked DMF exposure to potential carcinogenic effects and suspected congenital disabilities, leading to regulatory restrictions in certain regions, particularly limiting women's exposure in workplaces handling DMF. While the International Agency for Research on Cancer (IARC) classifies DMF as a possible carcinogen, the U.S. Environmental Protection Agency (EPA) does not consider it a definitive cancer risk. Nonetheless, acute exposure to DMF can cause severe health issues, including liver failure, as reported by the EPA, which represents a critical challenge to its market acceptance and growth. Consequently, many industries are shifting toward safer alternatives, such as dimethyl sulfoxide (DMSO), to mitigate health risks.

Key Market Drivers

Growing Demand of Dimethylformamide from Pharmaceutical Industry

Dimethylformamide (DMF) is a critical organic solvent extensively used in the pharmaceutical industry, playing a vital role in the manufacturing of various drugs, including antibiotics, antivirals, and pharmaceutical adjuvants. Its widespread adoption stems from its superior solvent capabilities, excellent chemical stability, and low evaporation rate, making it essential in numerous drug production processes. India's pharmaceutical industry, valued at approximately USD 58 billion currently, is expected to expand significantly, reaching USD 125 billion by 2030 and USD 425 billion by 2047. This rapid growth in the pharmaceutical sector is a key driver for the dimethylformamide (DMF) market, as DMF is widely used as a critical solvent in drug manufacturing. The industry's expansion will increase demand for DMF, supporting its market growth and encouraging further innovation and production to meet evolving pharmaceutical needs.

The pharmaceutical sector's rapid growth, driven by global health challenges and increased drug demand, has significantly boosted the market for DMF. This rising demand has prompted manufacturers to focus on enhancing the quality and efficiency of DMF to better meet the evolving requirements of pharmaceutical production. Beyond its traditional applications, DMF is increasingly utilized in innovative pharmaceutical technologies, such as advanced drug delivery systems, expanding its scope and value within the industry. This diversification underscores DMF's adaptability and its critical contribution to pharmaceutical innovation.

As the global pharmaceutical market continues to expand, propelled by the development of new drugs and cutting-edge delivery methods, the demand for DMF is projected to grow correspondingly. Manufacturers are expected to invest further in research and development to improve DMF formulations, ensuring compliance with stringent quality standards and supporting the pharmaceutical industry's dynamic needs. The pharmaceutical industry represents a key growth driver for the global DMF market. The sector's ongoing expansion and innovation are expected to sustain and accelerate demand for DMF, reinforcing its strategic importance. As pharmaceutical companies continue to develop novel therapies and delivery platforms, DMF will remain an indispensable solvent, underpinning the future growth and evolution of the global DMF market.

Key Market Challenges

Volatility in Cost of Raw Materials

DMF (Dimethylformamide) is a versatile organic compound extensively used as a solvent in various industries, including pharmaceuticals, agriculture, and chemical production. Its widespread application stems from its excellent solvency properties and compatibility with different substances. However, the production of DMF is not without its complexities.

The manufacturing process of DMF involves the utilization of several raw materials, each of which contributes to the overall cost of production. These raw materials are subject to market dynamics and can experience fluctuations due to various factors, such as supply disruptions, demand spikes, and trade restrictions. The volatility in raw material prices adds an additional layer of complexity to the DMF market.

In recent times, the DMF market has witnessed a sustained decline in price trends. This downward trajectory can be partly attributed to the weak methanol prices and a steady demand from downstream industries. While this may seem beneficial for manufacturers in the short term, it introduces a level of unpredictability that can make long-term planning and investment decisions challenging.

Fluctuating raw material costs can significantly impact manufacturers' profit margins. When these costs rise, manufacturers are faced with a difficult choice - either absorb the increased costs, resulting in reduced profits, or pass them onto customers, potentially leading to a decrease in demand. Such market dynamics can create a delicate balance for manufacturers to maintain their competitiveness while ensuring sustainable profitability.

Key Market Trends

Growing Demand of High-Purity DMF

High-purity DMF, a refined version of the organic compound, is extensively used as a solvent and reagent in the pharmaceutical industry. Its exceptional properties, including high solvent power, excellent chemical stability, and low evaporation rate, make it a vital component in the manufacture of various drugs. From antibiotics to antiviral medications and pharmaceutical adjuvants, high-purity DMF plays a crucial role in ensuring the purity and efficacy of these pharmaceutical products.

The pharmaceutical sector's preference for high-purity DMF stems from its ability to maintain strict purity levels, preventing contamination that could compromise the quality of drugs. As the demand for pharmaceuticals surges, especially in the face of the ongoing global health crisis, the need for high-purity DMF has significantly increased. This growing demand is driving the growth of the DMF market, as manufacturers strive to meet the requirements of the expanding pharmaceutical industry.

The growing demand for high-purity dimethylformamide from the pharmaceutical industry represents a major trend in the global DMF market. As the pharmaceutical sector continues to expand and evolve, this trend is expected to play an even more significant role in shaping the future of the DMF market. The critical role of high-purity DMF in drug manufacturing processes underscores its importance in ensuring the safety and efficacy of pharmaceutical products, making it an indispensable component in the pharmaceutical industry's pursuit of innovation and excellence.

Key Market Players

• BASF SE
• Balaji Amines Ltd.
• Bell Chem Corp
• Methanol Chemicals Co.
• Eastman Chemical Company
• Jiutian Chemical Group Ltd.
• Luxi Group Co Ltd
• Mitsubishi Gas Chemical Company Inc.
• PON Pure Chemical India Pvt Ltd
• Shandong Hualu-Hengsheng Chemical Co., Ltd.

Report Scope:

In this report, the Global Dimethylformamide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dimethylformamide Market, By Type:

• Reactant
• Feedstock

Dimethylformamide Market, By End User:

• Chemical
• Electronics
• Pharmaceutical
• Agriculture

Dimethylformamide Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dimethylformamide Market.

Available Customizations:

Global Dimethylformamide Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Dimethylformamide Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value & Volume
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Reactant, Feedstock)
  • 4.2.2. By End User (Chemical, Electronics, Pharmaceutical, Agriculture)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By End User
  • 4.3.3. By Region

5. Asia Pacific Dimethylformamide Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By End User
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Dimethylformamide Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value & Volume
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By End User
  • 5.3.2. India Dimethylformamide Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value & Volume
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By End User
  • 5.3.3. Australia Dimethylformamide Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value & Volume
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By End User
  • 5.3.4. Japan Dimethylformamide Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value & Volume
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By End User
  • 5.3.5. South Korea Dimethylformamide Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value & Volume
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By End User

6. Europe Dimethylformamide Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Dimethylformamide Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value & Volume
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Germany Dimethylformamide Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value & Volume
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Spain Dimethylformamide Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value & Volume
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User
  • 6.3.4. Italy Dimethylformamide Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value & Volume
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By End User
  • 6.3.5. United Kingdom Dimethylformamide Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value & Volume
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By End User

7. North America Dimethylformamide Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Dimethylformamide Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value & Volume
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Mexico Dimethylformamide Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value & Volume
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Canada Dimethylformamide Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value & Volume
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User

8. South America Dimethylformamide Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Dimethylformamide Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value & Volume
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Argentina Dimethylformamide Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value & Volume
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Colombia Dimethylformamide Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value & Volume
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User

9. Middle East and Africa Dimethylformamide Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Dimethylformamide Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value & Volume
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Saudi Arabia Dimethylformamide Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value & Volume
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. UAE Dimethylformamide Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value & Volume
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User
  • 9.3.4. Egypt Dimethylformamide Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value & Volume
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Dimethylformamide Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. BASF SE
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Balaji Amines Ltd.
• 14.3. Bell Chem Corp
• 14.4. Methanol Chemicals Co.
• 14.5. Eastman Chemical Company
• 14.6. Jiutian Chemical Group Ltd.
• 14.7. Luxi Group Co Ltd
• 14.8. Mitsubishi Gas Chemical Company Inc.
• 14.9. PON Pure Chemical India Pvt Ltd
• 14.10. Shandong Hualu-Hengsheng Chemical Co., Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer